The biotechnology sector continues to ride a massive wave of medical innovation, and ETFs like the ALPS Medical Breakthroughs ETF (SBIO) appear to be capturing the upside.  SBIO posted a solid 5% gain in August, fueled by positive clinical trial data and an accelerating pace of industry mergers and acquisitions. Key Takeaways SBIO gained 5% […]

The post SBIO ETF Rallies on Clinical Trial Wins & M&A Demand appeared first on ETF Trends.